Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest From Daniel Chapter One

Enforcement Roundup: Daniel Chapter One, Peanut Corp. Of America

Final chapter for Daniel Chapter One owner; prison sentence for head of salmonella-tainted peanut firm.

United States Business Strategies

Enforcement Roundup: Daniel Chapter One, Peanut Corp. Of America

Final chapter for Daniel Chapter One owner; prison sentence for head of salmonella-tainted peanut firm.

United States Business Strategies

Health Claims Advocates Suggest FDA Pull New Dietary Ingredient Guidance

Citizens for Health makes more radical comments than most about NDI notification FDA’s draft guidance, asking the agency to withdraw it. The group further asks FDA to declare that it “will not, now or ever” enforce under any “re-interpretation” of DSHEA.

Consumer United States

Health Claims Advocates Suggest FDA Pull New Dietary Ingredient Guidance

Citizens for Health makes more radical comments than most about NDI notification FDA’s draft guidance, asking the agency to withdraw it. The group further asks FDA to declare that it “will not, now or ever” enforce under any “re-interpretation” of DSHEA.

Consumer United States
See All
UsernamePublicRestriction

Register